Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

0FDB

Navamedic Asa (0FDB)

Navamedic Asa
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0FDB
일자시간출처헤드라인심볼기업
2023/12/2201:29PR Newswire (US)Navamedic ASA: Renewed contract signed with Vitaflo International LimitedLSE:0FDBNavamedic Asa
2023/12/1403:18PR Newswire (US)Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in EuropeLSE:0FDBNavamedic Asa
2023/11/0116:14PR Newswire (US)Navamedic ASA: Record high quarter with above 50 percent growthLSE:0FDBNavamedic Asa
2023/10/2718:52PR Newswire (US)Navamedic ASA: Invitation to 2023 3rd quarter presentationLSE:0FDBNavamedic Asa
2023/08/3020:20PR Newswire (US)Navamedic ASA - Registration of share capital increaseLSE:0FDBNavamedic Asa
2023/08/1819:50PR Newswire (US)Navamedic ASA - Mandatory notification of trade by primary insiderLSE:0FDBNavamedic Asa
2023/08/1819:27PR Newswire (US)NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee optionsLSE:0FDBNavamedic Asa
2023/08/1115:41PR Newswire (US)Navamedic ASA: Significant growth across the businessLSE:0FDBNavamedic Asa
2023/08/0719:40PR Newswire (US)Navamedic ASA: Invitation to 2023 2nd quarter presentationLSE:0FDBNavamedic Asa
2023/06/0118:43PR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
2023/05/3121:42PR Newswire (US)Updated recommendation by the nomination committee of Navamedic ASALSE:0FDBNavamedic Asa
2023/05/2615:23PR Newswire (US)Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offerLSE:0FDBNavamedic Asa
2023/05/1119:15PR Newswire (US)Navamedic ASA: Notice of Annual General MeetingLSE:0FDBNavamedic Asa
2023/05/1115:57PR Newswire (US)Navamedic ASA Q1 2023: Another strong quarterLSE:0FDBNavamedic Asa
2023/05/1016:15PR Newswire (US)Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose AktiebolagLSE:0FDBNavamedic Asa
2023/05/0818:25PR Newswire (US)Navamedic ASA: Invitation to 2023 1st quarter presentationLSE:0FDBNavamedic Asa
2023/04/2820:57PR Newswire (US)Navamedic ASA: Annual Report for 2022LSE:0FDBNavamedic Asa
2023/04/2412:34PR Newswire (US)Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose ABLSE:0FDBNavamedic Asa
2023/03/2915:13PR Newswire (US)Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 millionLSE:0FDBNavamedic Asa
2023/02/1617:00PR Newswire (US)Navamedic ASA: Q4 2022 financial resultsLSE:0FDBNavamedic Asa
2023/02/1317:19PR Newswire (US)Navamedic ASA: Invitation to 2022 4th quarter presentationLSE:0FDBNavamedic Asa
2022/11/2319:30PR Newswire (US)Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic regionLSE:0FDBNavamedic Asa
2022/11/0116:43PR Newswire (US)Navamedic ASA: Q3 2022 financial resultsLSE:0FDBNavamedic Asa
2022/10/2523:01PR Newswire (US)Navamedic ASA: Invitation to 2022 third quarter presentationLSE:0FDBNavamedic Asa
2022/10/2016:24PR Newswire (US)Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipationLSE:0FDBNavamedic Asa
2022/08/1215:48PR Newswire (US)Navamedic ASA: Q2 and first half 2022 financial resultsLSE:0FDBNavamedic Asa
2022/08/0921:40PR Newswire (US)Navamedic ASA: Invitation to 2022 second quarter presentationLSE:0FDBNavamedic Asa
2022/08/0421:27PR Newswire (US)Navamedic ASA - Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®LSE:0FDBNavamedic Asa
2022/07/0503:13PR Newswire (US)Navamedic ASA: Trading UpdateLSE:0FDBNavamedic Asa
2022/06/0221:05PR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
 검색 관련기사 보기:LSE:0FDB